17-18157060-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_016239.4(MYO15A):c.8708G>A(p.Arg2903Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000374 in 1,613,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016239.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO15A | NM_016239.4 | c.8708G>A | p.Arg2903Gln | missense_variant | 49/66 | ENST00000647165.2 | NP_057323.3 | |
MYO15A | XM_017024715.3 | c.8711G>A | p.Arg2904Gln | missense_variant | 47/64 | XP_016880204.1 | ||
MYO15A | XM_017024714.3 | c.8648G>A | p.Arg2883Gln | missense_variant | 46/63 | XP_016880203.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000245 AC: 61AN: 248826Hom.: 0 AF XY: 0.000288 AC XY: 39AN XY: 135254
GnomAD4 exome AF: 0.000393 AC: 574AN: 1461696Hom.: 0 Cov.: 32 AF XY: 0.000424 AC XY: 308AN XY: 727160
GnomAD4 genome AF: 0.000197 AC: 30AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74376
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Oct 28, 2022 | BP4, PM2_supporting - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 15, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Sep 04, 2014 | Variant classified as Uncertain Significance - Favor Benign. The Arg2903Gln vari ant in MYO15A has not been previously reported in individuals with hearing loss, but has been identified in 0.07% (6/8308) of European American chromosomes by t he NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs20 0781310). The arginine (Arg) residue at position 2903 is not fully conserved in mammals and across evolutionarily distant species, with one mammal (squirrel mon key) having glutamine (Gln) at this position, which raises the possibility that this change may be tolerated. Additional computational prediction tools do not p rovide strong support for or against an impact to the protein. In summary, while the clinical significance of the Arg2903Gln variant is uncertain, the frequency and conservation data suggest that it is more likely to be benign. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | The c.8708G>A (p.R2903Q) alteration is located in exon 49 (coding exon 48) of the MYO15A gene. This alteration results from a G to A substitution at nucleotide position 8708, causing the arginine (R) at amino acid position 2903 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Autosomal recessive nonsyndromic hearing loss 3 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 03, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at